Chemo-radiotherapy

RADIATION4 trials

Sponsors

Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR, Institut du Cancer de Montpellier - Val d'Aurelle, Ontario Clinical Oncology Group (OCOG), University of Manchester

Conditions

Lung CancerRectal AdenocarcinomaRectal Cancernon-small cell lung cancer

Phase 1

A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer

Active, not recruitingJPRN-UMIN000001540

Shizuoka Cancer Center, The Cancer Institute Hospital of JFCRnon-small cell lung cancer

Start: 2007-09-01Target: 27Updated: 2026-06-29

Phase 2

Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy

TerminatedNCT02115464

Ontario Clinical Oncology Group (OCOG)Lung Cancer

Start: 2014-12-17End: 2020-04-21Updated: 2020-04-22

Phase 3

Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal Carcinoma

CompletedNCT00979680

Institut du Cancer de Montpellier - Val d'AurelleRectal Cancer

Start: 2001-04-30End: 2007-09-30Updated: 2023-06-29

Unknown Phase

Optimisation of Radiotherapy in Rectal Cancer (ORREC)

University of ManchesterRectal Adenocarcinoma

Start: 2019-09-23End: 2021-03-31Target: 1500Updated: 2019-09-16

Related Papers

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.

2024-11-073 citations

Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer

JAMA Oncology2021-07-29101 citations